JUPW - Jupiter Wellness says developing a new women's sexual health product
- Jupiter Wellness ( NASDAQ: JUPW ) on Wednesday said it is developing a new product for women's sexual health called RJ-101.
- RJ-101 will address a wide range of clinical indications including female orgasmic disorder, nipple neuropathies after breast augmentation, and orgasmic adverse events in breast cancer survivors.
- RJ-101 can also be used by normal women to enhance the sensitivity of the nipple and thus their orgasmic response.
- JUPW said RJ-101 is covered by two issued U.S. patents - patent number 10,357,452 and patent number 10,064,816.
- JUPW stock opened 3.6% higher at $0.73.
For further details see:
Jupiter Wellness says developing a new women’s sexual health product